CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE IN PEDIATRIC ONCOLOGY

被引：2
|
作者：
KUSHNER, BH
CHEUNG, NKV
机构：
来源：
LANCET | 1990年 / 336卷 / 8709期
关键词：
D O I：
10.1016/0140-6736(90)91785-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [31] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS
    BRAMWELL, VHC
    MOURIDSEN, HT
    SANTORO, A
    BLACKLEDGE, G
    SOMERS, R
    VERWEIJ, J
    DOMBERNOWSKY, P
    ONSRUD, M
    THOMAS, D
    SYLVESTER, R
    VANOOSTEROM, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 : S180 - S184
  • [32] GYNECOLOGIC ONCOLOGY GROUP STUDIES WITH IFOSFAMIDE
    SUTTON, GP
    BLESSING, JA
    MANETTA, A
    HOMESLEY, H
    MCGUIRE, W
    SEMINARS IN ONCOLOGY, 1992, 19 (06) : 31 - 35
  • [33] GYNECOLOGIC ONCOLOGY GROUP EXPERIENCE WITH IFOSFAMIDE
    SUTTON, GP
    BLESSING, JA
    PHOTOPULOS, G
    BERMAN, ML
    HOMESLEY, HD
    SEMINARS IN ONCOLOGY, 1990, 17 (02) : 6 - 10
  • [34] Toxicity of chemotherapeutical protocols in the treatment of uterine sarcomas (Vincristine, actinomycin D, Cyclophosphamide VAC versus ifosfamide)
    Simsek, T
    Uner, M
    Trak, B
    Erman, O
    Zorlu, GC
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (04) : 405 - 407
  • [35] WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study
    Souid, AK
    Fahey, RC
    Dubowy, RL
    Newton, GL
    Bernstein, ML
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (06) : 498 - 504
  • [36] Ifosfamide in the treatment of pediatric malignancies
    Voute, PA
    vandenBerg, H
    Behrendt, H
    Michiels, E
    deKraker, J
    SEMINARS IN ONCOLOGY, 1996, 23 (03) : 8 - 11
  • [37] Ifosfamide in pediatric solid tumors
    Carli, M
    Passone, E
    Perilongo, G
    Bisogno, G
    ONCOLOGY, 2003, 65 : 99 - 104
  • [38] WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study
    Abdul-Kader Souid
    Robert C. Fahey
    Ronald L. Dubowy
    Gerald L. Newton
    Mark L. Bernstein
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 498 - 504
  • [39] Tandem mass spectrometric analysis of cyclophosphamide, ifosfamide and their metabolites
    Liu, ZF
    Chan, KK
    Wang, JJ
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (18) : 2581 - 2590
  • [40] COMPARATIVE-STUDIES ON BIOLOGICAL-ACTIVITY OF /+/R AND /-/S ENANTIOMERS OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE .1. ANTITUMOR EFFECT OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE ENANTIOMERS
    PAPROCKA, M
    KUSNIERCZYK, H
    BUDZYNSKI, W
    RAK, J
    RADZIKOWSKI, C
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1986, 34 (03) : 275 - 284
12345